{"DataElement":{"publicId":"2002339","version":"3","preferredName":"Patient Therapeutic Procedure Follow-up Eligibility Determination Ind-2","preferredDefinition":"the yes/no indicator whether a patient or participant has agreed to return to receive treatment, an action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process or follow-up, the process by which information about the health status of an individual is obtained after a study has officially closed, as part of the act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","longName":"PT_TX_FU_ELIG_IND","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2778717","version":"1","preferredName":"Patient Therapeutic Procedure Follow-up Eligibility Determination","preferredDefinition":"information related to a patient or participant receiving treatment, an action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process or follow-up, the process by which information about the health status of an individual is obtained after a study has officially closed, as part of the act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","longName":"PT_TX_FU_ELIG","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2233604","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D847-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2778715","version":"1","preferredName":"Therapeutic Procedure Follow-up Eligibility Determination","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.:The process by which information about the health status of an individual is obtained after a study has officially closed.:Criteria to determine eligibility of patients for medical care programs and services.","longName":"C49236:C16033:C25171","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Follow-Up","conceptCode":"C16033","definition":"The process by which information about the health status of an individual is obtained after a study has officially closed; an activity that continues something that has already begun or that repeats something that has already been done.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Eligibility Determination","conceptCode":"C25171","definition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5574FD25-A193-286F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-08-27","modifiedBy":"ONEDATA","dateModified":"2008-08-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5574FD25-A1A4-286F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-08-27","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811954","version":"1","longName":"Eligibility Criteria","context":"CTEP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104890","version":"1","longName":"GOG-0229L","context":"NRG"}]},{"publicId":"6147165","version":"1","longName":"Wake Forest Baptist Medical Center","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6147167","version":"1","longName":"WFB","context":"NCIP"}]}],"AlternateNames":[{"name":"PT_TX_FU_ELIG_IND","type":"USED_BY","context":"NRG"},{"name":"CCTG","type":"USED_BY","context":"CCTG"},{"name":"PT_TX_FU_ELIG_IND","type":"USED_BY","context":"CCTG"},{"name":"NCIP","type":"USED_BY","context":"NCIP"},{"name":"IE_IEORRES_FOLLOW","type":"OID, CCTG","context":"CCTG"},{"name":"IE_IEORRES_CROS_FOLLOW","type":"OID, CCTG","context":"CCTG"}],"ReferenceDocuments":[{"name":"Patient accessible for treatm","type":"Preferred Question Text","description":"Patient accessible for treatment and follow-up.","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Patient Follow-up Accessible Indicator","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Willingness to return to an NCCTG or other participating cooperative group institution for treatment and follow-up","url":null,"context":"CTEP"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Subject is accessible for treatment and follow-up","url":null,"context":"CTEP"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Willingness to return to NCCTG or ABTC enrolling institution for follow-up","url":null,"context":"CTEP"},{"name":"CRF Text7","type":"Alternate Question Text","description":"Willingness to return to NCCTG enrolling institution for follow-up","url":null,"context":"CTEP"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Is the patient available for follow-up assessments?","url":null,"context":"CTEP"},{"name":"CRF Text8","type":"Alternate Question Text","description":"Willing to return to NCCTG enrolling institution for follow-up","url":null,"context":"CTEP"},{"name":"CRF Text9","type":"Alternate Question Text","description":"Willingness to return to NCCTG enrolling institution for treatment and follow-up","url":null,"context":"CTEP"},{"name":"CRF Text12","type":"Alternate Question Text","description":"Willingness to return to Alliance enrolling institution for follow-up","url":null,"context":"CTEP"},{"name":"CRF Text10","type":"Alternate Question Text","description":"Willing to return to enrolling medical site for all study visits","url":null,"context":"CTEP"},{"name":"CRF Text11","type":"Alternate Question Text","description":"Willing to return to enrolling medical site for all study assessments","url":null,"context":"CTEP"},{"name":"CRF Text6","type":"Alternate Question Text","description":"Willingness to return to Alliance or ABTC enrolling institution for follow-up","url":null,"context":"CTEP"},{"name":"CE7","type":"Alternate Question Text","description":"Patient is accessible for treatment and follow-up.","url":null,"context":"CCTG"},{"name":"WF1804","type":"Alternate Question Text","description":"Able and willing to complete a follow-up assessment in one year","url":null,"context":"NCIP"},{"name":"CCTG_01","type":"Alternate Question Text","description":"Patient will be accessible for treatment and follow-up, and will be treated and followed at the participating centre?","url":null,"context":"CCTG"},{"name":"CCTG_02","type":"Alternate Question Text","description":"Patients must be accessible for treatment, response assessment, and follow up.","url":null,"context":"CCTG"},{"name":"CCTG_03","type":"Alternate Question Text","description":"Patients who discontinued everolimus due to toxicity will only be permitted to crossover if they have remained in compliance with protocol follow up criteria for disease assessment after discontinuation of everolimus.","url":null,"context":"CCTG"},{"name":"CCTG_04","type":"Alternate Question Text","description":"Participant will be accessible for treatment and follow-up per protocol section 4.1.8 and will be treated and followed at the participating centre.","url":null,"context":"CCTG"}],"origin":"NCIC CRF:National Cancer Institute of Canada Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A1AD2C16-8879-1953-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-05-23","endDate":null,"createdBy":"PWEST","dateCreated":"2002-05-23","modifiedBy":"CLOHNES","dateModified":"2023-11-16","changeDescription":"Replaced VD Eligibility Ind-2 2018257v1 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":"11/16/23 Added alt OID and AQT for CCTG ticket number CADSR0003085 cjl; 3/7/23 added 1 alt OID and 1 AQT for CCTG ticket request CADSR0002117 cjl; 12/21/22 added AQT for ticket number CADSR0001818 cjl.","unresolvedIssues":null,"deletedIndicator":"No"}}